$27MSeries A, 11 March 2026
Series A funds its agentic FP&A platform for health systems such as Northwestern Medicine.
- Amount
- $27M
- Stage
- Series A
- Announced
- 11 March 2026
- Lead
- GV
- Other investors
- NEA, FPV Ventures, Virtue
- Use of funds
- Series A funds its agentic FP&A platform for health systems such as Northwestern Medicine.
- Checked
- Announced by the company
- Sources
- Translucent raises $27M Series A led by GV businesswire.com
Translucent raises $27M Series A led by GV pulse2.com